The University Medical Center Utrecht is the main hospital of the city of Utrecht, Netherlands. It is affiliated with the Utrecht University. Since the foundation of the university in 1636 an academic hospital has existed in various forms.

During the past decade, University Medical Center Utrecht conducted 493 clinical trials. In the 10-year time frame, 493 clinical trials started and 114 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 222 clinical trials started and 80 clinical trials were completed. i.e. 36% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center Utrecht" #1 sponsor was "UMC Utrecht" with 206 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 36 trials sponsored, "Radboud University Medical Center" with 28 trials sponsored, "The Netherlands Cancer Institute" with 21 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 21 trials sponsored. Other sponsors include 503 different institutions and companies that sponsored additional 245 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center Utrecht" #1 collaborator was "UMC Utrecht" with 57 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 53 trials as a collaborator, "Erasmus Medical Center" with 31 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 24 trials as a collaborator and "Dutch Cancer Society" with 20 trials as a collaborator. Other collaborators include 1035 different institutions and companies that were collaborators in the rest 638 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center Utrecht" are "Amyotrophic Lateral Sclerosis" (20 trials), "Breast Cancer" (20 trials), "Hypertension" (17 trials), "Cystic Fibrosis" (15 trials) and "Colorectal Cancer" (14 trials). Many other conditions were trialed in "University Medical Center Utrecht" in a lesser frequency.

Most popular intervention types in "University Medical Center Utrecht" are "Drug" (413 trials), "Device" (116 trials), "Procedure" (101 trials), "Other" (98 trials) and "Biological" (50 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (103 trials), "Dexamethasone" (13 trials), "Cyclophosphamide" (12 trials), "cisplatin" (11 trials) and "radiation therapy" (10 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center Utrecht" are 716 trials for "All" genders, 74 trials for "Female" genders and 25 trials for "Male" genders.

Currently, there are 273 active trials in "University Medical Center Utrecht". 12 are not yet recruiting, 157 are recruiting, 93 are Active, not recruiting, and 11 are Enrolling by invitation. In total, there were 360 completed trials in University Medical Center Utrecht, 1 suspended trials, and 85 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center Utrecht, 57 "Phase 1" clinical trials were conducted, 165 "Phase 2" clinical trials and 244 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 54 trials, and there were also 172 trials that are defined as “Not Applicable".

University Medical Center Utrecht has several departments that took part in Clinical trials: "Dept. of Child and Adolescent Psychiatry, UMC Utrecht" - 7 trials, "UMC Utrecht, Dept. of Internal Medicine, MDL" - 3 trials, "Department of Vascular Medicine UMC Utrecht" - 3 trials, "UMC Utrecht Cancer Center" - 6 trials, "UMC Utrecht; Polkliniek Neuromusculaire ziekten" - 3 trials, "University Medical Centre Utrecht; Reumatologie en Klinische Immunologie" - 2 trials, "University Medical Center - Hematology" - 2 trials